Neurocognitive functioning of children treated for high-risk B-acute lymphoblastic leukemia randomly assigned to different methotrexate and corticosteroid treatment strategies: A report from the children's oncology group

Journal of Clinical Oncology

Volumn 35, Issue 23, 2017, Pages 2700-2707

  Hardy, Kristina K ^b   Embry, Leanne ^c   Kairalla, John A ^d   Helian, Shanjun ^f   Devidas, Meenakshi ^d   Armstrong, Daniel ^e   Hunger, Stephen ^g   Carroll, William L ⁱ   Larsen, Eric ^j   Raetz, Elizabeth A ^k   Loh, Mignon L ^l   Yang, Wenjian ^m   Relling, Mary V ^m   Noll, Robert B ^h   Winick, Naomi ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF MIAMI   (United States)

^f Merck Sharp & Dohme Limited   (United Kingdom)

^g CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^h UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

ⁱ NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^j Maine Children's Cancer Program Scarborough   (United States)

^k UNIVERSITY OF UTAH   (United States)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE MACROGOL; CYTARABINE; DEXAMETHASONE; FOLINIC ACID; METHOTREXATE; PREDNISONE; ANTINEOPLASTIC AGENT; ASPARAGINASE; CORTICOSTEROID; MACROGOL DERIVATIVE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER SURVIVOR; CENTRAL NERVOUS SYSTEM LEUKEMIA; CHILD; COGNITION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROSS-SECTIONAL STUDY; DRUG DOSE ESCALATION; DRUG MEGADOSE; ETHNICITY; FEMALE; GENDER; HIGH RISK PATIENT; HUMAN; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PUBLIC HEALTH INSURANCE; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; WORKING MEMORY; AGE; CHILDHOOD TRAUMA SURVIVOR; DRUG EFFECTS; HEALTH INSURANCE; INTELLIGENCE; MEDICAID; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PSYCHOLOGY; REACTION TIME; SHORT TERM MEMORY; UNITED STATES;

ADRENAL CORTEX HORMONES; ADULT SURVIVORS OF CHILD ADVERSE EVENTS; AGE FACTORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; CHILD; COGNITION; DEXAMETHASONE; FEMALE; HUMANS; INSURANCE, HEALTH; INTELLIGENCE; LEUCOVORIN; MALE; MEDICAID; MEMORY, SHORT-TERM; METHOTREXATE; POLYETHYLENE GLYCOLS; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREDNISONE; REACTION TIME; UNITED STATES;

EID: 85028762924     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2016.71.7587     Document Type: Article

References (48)

1. Campbell LK, Scaduto M, Sharp W, et al: A meta-analysis of the neurocognitive sequelae of treatment for childhood acute lymphocytic leukemia. Pediatr Blood Cancer 49:65-73, 2007
2. Mennes M, Stiers P, Vandenbussche E, et al: Attention and information processing in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only. Pediatr Blood Cancer 44: 478-486, 2005
3. Jacola LM, Krull KR, Pui C-H, et al: Longitudinal assessment of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia treated on a contemporary chemotherapy protocol. J Clin Oncol 34:1239-1247, 2016
4. Peterson CC, Johnson CE, Ramirez LY, et al: A meta-analysis of the neuropsychological sequelae of chemotherapy-only treatment for pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer 51: 99-104, 2008
5. Knight S, McCarthy M, Anderson V, et al: Visuomotor function in children treated for acute lymphoblastic leukaemia with chemotherapy only. Dev Neuropsychol 39:101-112, 2014
6. Iyer NS, Balsamo LM, Bracken MB, et al: Chemotherapy-only treatment effects on long-term neurocognitive functioning in childhood ALL survivors: A review and meta-analysis. Blood 126: 346-353, 2015
7. Pui C-H, Campana D, Pei D, et al: Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med 360:2730-2741, 2009
8. Conklin HM, Krull KR, Reddick WE, et al: Cognitive outcomes following contemporary treatment without cranial irradiation for childhood acute lymphoblastic leukemia. J Natl Cancer Inst 104: 1386-1395, 2012
9. Halsey C, Buck G, Richards S, et al: The impact of therapy for childhood acute lymphoblastic leukaemia on intelligence quotients: Results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI. J Hematol Oncol 4:42, 2011
10. Jain N, Brouwers P, Okcu MF, et al: Sex-specific attention problems in long-term survivors of pediatric acute lymphoblastic leukemia. Cancer 115:4238-4245, 2009
11. Patel SK, Lo TTY, Dennis JM, et al: Neurocognitive and behavioral outcomes in Latino childhood cancer survivors. Pediatr Blood Cancer 60: 1696-1702, 2013
12. Butler RW, Fairclough DL, Katz ER, et al: Intellectual functioning and multi-dimensional attentional processes in long-term survivors of a central nervous system related pediatric malignancy. Life Sci 93:611-616, 2013
13. Kunin-Batson A, Kadan-Lottick N, Zhu L, et al: Predictors of independent living status in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer 57:1197-1203, 2011
14. Aukema EJ, Caan MWA, Oudhuis N, et al: White matter fractional anisotropy correlates with speed of processing and motor speed in young childhood cancer survivors. Int J Radiat Oncol Biol Phys 74:837-843, 2009
15. Krull KR, Bhojwani D, Conklin HM, et al: Genetic mediators of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia. J Clin Oncol 31:2182-2188, 2013
16. Krawczuk-Rybak M, Grabowska A, Protas PT, et al: Intellectual functioning of childhood leukemia survivors–relation to Tau protein–A marker of white matter injury. Adv Med Sci 57: 266-272, 2012
17. Nathan PC, Whitcomb T, Wolters PL, et al: Very high-dose methotrexate (33.6 g/m2) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: Results of National Cancer Institute/Children's Cancer Group trials CCG-191P, CCG-134P and CCG-144P. Leuk Lymphoma 47:2488-2504, 2006
18. Waber DP, McCabe M, Sebree M, et al: Neuropsychological outcomes of a randomized trial of prednisone versus dexamethasone in acute lymphoblastic leukemia: Findings from Dana-Farber Cancer Institute All Consortium Protocol 00-01. Pediatr Blood Cancer 60:1785-1791, 2013
19. Larsen EC, Devidas M, Chen S, et al: Dexamethasone and high-dose methotrexate improve outcome for children and young adults with high-risk B-acute lymphoblastic leukemia: A report from Children's Oncology Group Study AALL0232. J Clin Oncol 34:2380-2388, 2016
20. Embry L, Annett RD, Kunin-Batson A, et al: Implementation of multi-site neurocognitive assessments within a pediatric cooperative group: Can it be done? Pediatr Blood Cancer 59:536-539, 2012
21. Karol SE, Yang W, Van Driest SL, et al: Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia. Blood 126:1770-1776, 2015
22. Wechsler D: Wechsler Adult Intelligence Scale (ed 3). San Antonio, TX, The Psychological Corporation, 1997
23. Wechsler D: Wechsler Preschool and Primary Scale of Intelligence (ed 3). San Antonio, TX, The Psychological Corporation, 2002
24. Wechsler D: Wechsler Intelligence Scale for Children (ed 3). San Antonio, TX, The Psychological Corporation, 2003
25. Sattler JM: Resource Guide to Accompany Assessment of Children: Cognitive Foundations (ed 5). San Diego, CA, Jerome M. Sattler Publisher, 2008
26. Cole PD, Finkelstein Y, Stevenson KE, et al: Polymorphisms in genes related to oxidative stress are associated with inferior cognitive function after therapy for childhood acute lymphoblastic leukemia. J Clin Oncol 33:2205-2211, 2015
27. Kamdar KY, Krull KR, El-Zein RA, et al: Folate pathway polymorphisms predict deficits in attention and processing speed after childhood leukemia therapy. Pediatr Blood Cancer 57:454-460, 2011
28. Krull KR, Brouwers P, Jain N, et al: Folate pathway genetic polymorphisms are related to attention disorders in childhood leukemia survivors. J Pediatr 152:101-105, 2008
29. Cheung YT, Krull KR: Neurocognitive outcomes in long-term survivors of childhood acute lymphoblastic leukemia treated on contemporary treatment protocols: A systematic review. Neurosci Biobehav Rev 53:108-120, 2015
30. Bhojwani D, Sabin ND, Pei D, et al: Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia. J Clin Oncol 32:949-959, 2014
31. Winick NJ, Bowman WP, Kamen BA, et al: Unexpected acute neurologic toxicity in the treatment of children with acute lymphoblastic leukemia. J Natl Cancer Inst 84:252-256, 1992
32. Dicuonzo F, Salvati A, Palma M, et al: Posterior reversible encephalopathy syndrome associated with methotrexate neurotoxicity: Conventional magnetic resonance and diffusion-weighted imaging findings. J Child Neurol 24:1013-1018, 2009
33. Parasole R, Petruzziello F, Menna G, et al: Central nervous system complications during treatment of acute lymphoblastic leukemia in a single pediatric institution. Leuk Lymphoma 51:1063-1071, 2010
34. Mahoney DH, Jr, Shuster JJ, Nitschke R, et al: Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: An association with intermediate-dose intravenous methotrexate and intrathecal triple therapy—A Pediatric Oncology Group study. J Clin Oncol 16:1712-1722, 1998
35. Kadan-Lottick NS, Brouwers P, Breiger D, et al: A comparison of neurocognitive functioning in children previously randomized to dexamethasone or prednisone in the treatment of childhood acute lymphoblastic leukemia. Blood 114:1746-1752, 2009
36. Ardila A, Rosselli M, Matute E, et al: The influence of the parents' educational level on the development of executive functions. Dev Neuropsychol 28:539-560, 2005
37. Gale CR, O'Callaghan FJ, Godfrey KM, et al: Critical periods of brain growth and cognitive function in children. Brain 127:321-329, 2004
38. Shaw P, Greenstein D, Lerch J, et al: Intellectual ability and cortical development in children and adolescents. Nature 440:676-679, 2006
39. Brooks-Gunn J, Duncan GJ: The effects of poverty on children. Future Child 7:55-71, 1997
40. Duncan GJ, Brooks-Gunn J, Klebanov PK: Economic deprivation and early childhood development. Child Dev 65:296-318, 1994
41. Shavers VL: Measurement of socioeconomic status in health disparities research. J Natl Med Assoc 99:1013-1023, 2007
42. Moore IM, Hockenberry MJ, Anhalt C, et al: Mathematics intervention for prevention of neurocognitive deficits in childhood leukemia. Pediatr Blood Cancer 59:278-284, 2012
43. Conklin HM, Ogg RJ, Ashford JM, et al: Computerized cognitive training for amelioration of cognitive late effects among childhood cancer survivors: A randomized controlled trial. J Clin Oncol 33: 3894-3902, 2015
44. Hardy KK, Willard VW, Allen TM, et al: Working memory training in survivors of pediatric cancer: A randomized pilot study. Psychooncology 22: 1856-1865, 2013
45. Butler RW, Copeland DR, Fairclough DL, et al: A multicenter, randomized clinical trial of a cognitive remediation program for childhood survivors of a pediatric malignancy. J Consult Clin Psychol 76: 367-378, 2008
46. Lee S-G, Joo Y, Kim B, et al: Association of Ala72Ser polymorphism with COMT enzyme activity and the risk of schizophrenia in Koreans. Hum Genet 116:319-328, 2005
47. Shifman S, Bronstein M, Sternfeld M, et al: A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 71: 1296-1302, 2002
48. Palmatier MA, Pakstis AJ, Speed W, et al: COMT haplotypes suggest P2 promoter region relevance for schizophrenia. Mol Psychiatry 9:859-870, 2004